377 related articles for article (PubMed ID: 32677614)
1. Prospective Randomized Trial Comparing Mitomycin C Combined with Ologen Implant versus Mitomycin C Alone as Adjuvants in Trabeculectomy.
Sen M; Midha N; Sidhu T; Angmo D; Sihota R; Dada T
Ophthalmol Glaucoma; 2018; 1(2):88-98. PubMed ID: 32677614
[TBL] [Abstract][Full Text] [Related]
2. Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh.
Sarker BK; Abdullahi SM; Hassan Z; Kabir J; Badmus S; Alam S; Rahman M; Malek MI; Mahatma M
Eur J Ophthalmol; 2019 Mar; 29(2):183-188. PubMed ID: 29701072
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.
Cillino S; Casuccio A; Di Pace F; Cagini C; Ferraro LL; Cillino G
BMC Ophthalmol; 2016 Mar; 16():24. PubMed ID: 26946419
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes of trabeculectomy with mitomycin C vs. ologen implant in primary glaucoma.
Senthil S; Rao HL; Babu JG; Mandal AK; Garudadri CS
Indian J Ophthalmol; 2013 Jul; 61(7):338-42. PubMed ID: 23571259
[TBL] [Abstract][Full Text] [Related]
5. Trabeculectomy with Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year Study.
El-Sayyad F; El-Saied HMA; Abdelhakim MASE
Ophthalmic Res; 2017; 57(4):230-238. PubMed ID: 28291960
[TBL] [Abstract][Full Text] [Related]
6. Using a collagen matrix implant (Ologen) versus mitomycin-C as a wound healing modulator in trabeculectomy with the Ex-PRESS mini glaucoma device: a 12-month retrospective review.
Johnson MS; Sarkisian SR
J Glaucoma; 2014 Dec; 23(9):649-52. PubMed ID: 24240882
[TBL] [Abstract][Full Text] [Related]
7. Combined trabeculotomy-trabeculectomy with and without augmentation in primary congenital glaucoma: triple-armed randomized controlled trial.
Khairy MA; Kenawy S; Fawzi KM; Al-Nashar HY
Int Ophthalmol; 2023 May; 43(5):1591-1600. PubMed ID: 36266601
[TBL] [Abstract][Full Text] [Related]
8. Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-a Collagen Matrix Implant: A 3-Year Follow-up Study.
Salimi A; Kovalyuk N; Harasymowycz PJ
J Glaucoma; 2019 Nov; 28(11):989-996. PubMed ID: 31567908
[TBL] [Abstract][Full Text] [Related]
9. Phacotrabeculectomy using collagen matrix implant (Ologen
Wlaź A; Wilkos-Kuc A; Rozegnał-Madej A; Żarnowski T
Acta Ophthalmol; 2019 Sep; 97(6):e817-e826. PubMed ID: 30924600
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of Trabeculectomy and Phacotrabeculectomy With Collagen Matrix Implant (Ologen) and Low-dose Mitomycin C: 2-Year Follow-up.
Castejón MA; Teus MA; Bolivar G; Paz-Moreno-Arrones J; Castaño B
J Glaucoma; 2018 Jan; 27(1):50-54. PubMed ID: 29117004
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Ologen Implant Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of Randomized Clinical Trials.
Ji Q; Qi B; Liu L; Guo X; Zhong J
J Glaucoma; 2015; 24(5):e88-94. PubMed ID: 25264995
[TBL] [Abstract][Full Text] [Related]
12. Trabeculectomy with OloGen versus Mitomycin C for the Treatment of Silicone Oil-Induced Glaucoma.
Shalaby HS; Hashem NH
Klin Monbl Augenheilkd; 2022 Sep; 239(9):1147-1154. PubMed ID: 34198351
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial.
Cillino S; Di Pace F; Cillino G; Casuccio A
Eye (Lond); 2011 Dec; 25(12):1598-606. PubMed ID: 21921953
[TBL] [Abstract][Full Text] [Related]
14. Ologen implant versus mitomycin C in combined trabeculectomy and phacoemulsification.
Paul C; Divya J; Kamal R; Paul A
Indian J Ophthalmol; 2022 Apr; 70(4):1248-1252. PubMed ID: 35326026
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year.
Narayanaswamy A; Perera SA; Htoon HM; Hoh ST; Seah SK; Wong TT; Aung T
Clin Exp Ophthalmol; 2013 Aug; 41(6):552-60. PubMed ID: 23279607
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Trabeculectomy Augmented With Subconjunctival and Subscleral Ologen Implantation in Primary Advanced Glaucoma.
Angmo D; Wadhwani M; Upadhyay AD; Temkar S; Dada T
J Glaucoma; 2017 Jan; 26(1):8-14. PubMed ID: 27599174
[TBL] [Abstract][Full Text] [Related]
17. Trabeculectomy with ologen in secondary glaucomas following failed trabeculectomy with MMC: comparative study.
El-Saied HM; Abdelhakim MA
Eye (Lond); 2016 Aug; 30(8):1126-34. PubMed ID: 27256305
[TBL] [Abstract][Full Text] [Related]
18. Ex-PRESS outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil.
Menda SA; Lowry EA; Porco TC; Stamper RL; Rubin MR; Han Y
Int Ophthalmol; 2015 Jun; 35(3):357-63. PubMed ID: 24920197
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcomes of repeat trabeculectomy augmented with high dose mitomycin C.
Rajendrababu S; Shroff S; Patil SV; Uduman MS; Vardhan A; Krishnadas SR
Indian J Ophthalmol; 2019 Jan; 67(1):95-100. PubMed ID: 30574901
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Outcomes of Trabeculectomy with 5-Fluorouracil versus Ologen Implant in Primary Open-Angle Glaucoma.
Shihadeh W; Massad I; Khader Y; Al-Rawi A; Alshalakhti T
Ophthalmic Res; 2017; 58(2):94-98. PubMed ID: 28468021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
